Press "Enter" to skip to content

HPV vaccine could reduce premature births

A virus vaccine has long-term benefits for recipients beyond reducing cancer, New Zealand research has unexpectedly shown.

The human papilloma virus (HPV) vaccine targets several variants of HPV, including those which have the highest risk of causing cancers, such as cervical cancer.

Spread by skin contact, HPV affects around 80 percent of the population at some time in their lives, with most cases occurring after sexual activity. In New Zealand, around 50 women die from cervical cancer each year.

Read more…

Comments are closed.